SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Varian Semiconductor Equipment Associates -- VSEA

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sherman Chen who wrote (1372)4/26/2001 9:05:51 AM
From: Proud_Infidel  Read Replies (2) of 1929
 
Varian Semiconductor Attains Number One Market Share Position
Dataquest Report Shows Varian Semiconductor as the Leading Ion Implantation Supplier and the Fastest Growing Major Semiconductor Capital Equipment Company
GLOUCESTER, Mass.--(BUSINESS WIRE)--April 26, 2001-- Company Gaining Share in All Segments

Varian Semiconductor Equipment Associates, Inc. (NASDAQ: VSEA - news), today announced the company has achieved the number one ion implantation supplier position, as well achieving the fastest growing major semiconductor capital equipment company status, according to a report just released by Dataquest. Varian Semiconductor led the industry in the ion implant market with 42 percent overall market share on a unit basis in calendar 2000, up 11 percentage points from calendar 1999.

``With the widespread acceptance of the new VIISta platform of ion implanters we have leveraged our single-wafer advantages to capture market share in the high current and high energy markets, as well as extending our lead in medium current,'' remarked Richard A. Aurelio, Varian Semiconductor's chairman and chief executive officer. ``This across-the-board increase in market share reflects our customers' acceptance of the throughput advantages of single-wafer processing and the economic benefits of our common platform, with its maximum production flexibility.''

The Dataquest research shows that Varian Semiconductor has increased its market share in all three ion implant segments with share gains in units of 6 percent in high current, 3 percent in high energy and 15 percent in the medium current market. Varian Semiconductor realized a majority of these gains through the sales of its new VIISta common platform of ion implanters in both the 200mm and 300mm marketplace.

``Our leadership in 300mm sales should also enable us to capture the next wave of market share gains,'' said Ernie Godshalk, Varian Semiconductor's president and chief operating officer. ``Since technology drives our business, these market share gains demonstrate that VIISta's single-wafer technology advantages provide the performance attributes necessary for the next generation of integrated circuits.''

About Varian Semiconductor

Varian Semiconductor Equipment Associates is a leading producer of ion implantation equipment used in the manufacture of semiconductors. The company is headquartered in Gloucester, Massachusetts, and operates worldwide. Varian Semiconductor maintains a web site at www.vsea.com. The information contained in our web site is not incorporated by reference into this release, and our web site address is included in this release as an inactive textual reference only.

Note: This press release contains forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. For this purpose, the statements concerning the company's operating outlook, market share and technology leadership are forward-looking statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, volatility in the semiconductor equipment industry; economic conditions in general and as they affect the company's customers; significant fluctuations in the company's quarterly operating results; the impact of rapid technological change and the company's dependence on the development and introduction of new products; the company's concentration on ion implantation systems and related products; concentration in the company's customer base and lengthy sales cycles; the highly competitive market in which the company competes; risks of international sales; foreign currency risks; general economic conditions; and other factors identified in the company's Annual Report on Form 10-K, and the most recent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. The company cannot guarantee any future results, levels of activity, performance or achievement. The company undertakes no obligation to update any of the forward-looking statements after the date of this press release.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext